Myocardial Functional Decline During Prolonged Ex Situ Heart Perfusion

Ann Thorac Surg. 2019 Aug;108(2):499-507. doi: 10.1016/j.athoracsur.2019.01.076. Epub 2019 Mar 12.

Abstract

Background: Myocardial function declines in a time-dependent fashion during ex situ heart perfusion. Cell death and metabolic alterations may contribute to this phenomenon, limiting the safe perfusion period and the potential of ex situ heart perfusion to expand the donor pool. Our aim was to investigate the etiology of myocardial functional decline in ex situ perfused hearts.

Methods: Cardiac function, apoptosis, effectors and markers of cell death, and metabolic function were assessed in healthy pig hearts perfused for 12 hours. These hearts were perfused in nonworking mode or working mode.

Results: Cardiac function declined during ex situ heart perfusion regardless of perfusion mode but was significantly better preserved in the hearts perfused in working mode (11-hour cardiac index/1-hour cardiac index: working mode, 33%; nonworking mode, 10%; p = 0.025). The rate of apoptosis was higher in the ex situ perfused hearts compared with in vivo samples (apoptotic cells: in vivo, 0.13%; working mode, 0.54%; nonworking mode, 0.88%; p < 0.001), but the absolute values were low and out of proportion to the decline in function in either group. Myocardial dysfunction at the end of the perfusion interval was partially rescued by delivery of a pyruvate bolus.

Conclusions: A significant decline in myocardial function occurs over time in hearts preserved ex situ that is out of proportion to the magnitude of myocyte cell death present in dysfunctional hearts. Alterations in myocardial substrate utilization during prolonged ex situ heart perfusion may contribute to this phenomenon and represent an avenue to improve donor heart preservation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Biomarkers / blood
  • Coronary Circulation / physiology*
  • Coronary Vessels / pathology
  • Coronary Vessels / physiopathology*
  • Disease Models, Animal
  • Female
  • Heart Transplantation / methods*
  • Myocardial Ischemia / metabolism
  • Myocardial Ischemia / pathology
  • Myocardial Ischemia / physiopathology*
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Organ Preservation / methods*
  • Perfusion / adverse effects*
  • Swine
  • Troponin I / blood

Substances

  • Biomarkers
  • Troponin I